Cargando…
Chlorogenic Acid Functions as a Novel Agonist of PPARγ2 during the Differentiation of Mouse 3T3-L1 Preadipocytes
Rosiglitazone (RG) is a well-known activator of peroxisome proliferator-activated receptor-gamma (PPARγ) and used to treat hyperglycemia and type 2 diabetes; however, its clinical application has been confounded by adverse side effects. Here, we assessed the roles of chlorogenic acid (CGA), a phenol...
Autores principales: | Peng, Shu-guang, Pang, Yi-lin, Zhu, Qi, Kang, Jing-he, Liu, Ming-xin, Wang, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304673/ https://www.ncbi.nlm.nih.gov/pubmed/30627576 http://dx.doi.org/10.1155/2018/8594767 |
Ejemplares similares
-
PPARγ agonist through the terminal differentiation phase is essential for adipogenic differentiation of fetal ovine preadipocytes
por: Pu, Yong, et al.
Publicado: (2017) -
FGF11 influences 3T3‐L1 preadipocyte differentiation by modulating the expression of PPARγ regulators
por: Lee, Kyeong Won, et al.
Publicado: (2019) -
Isoimperatorin enhances 3T3-L1 preadipocyte differentiation by regulating PPARγ and C/EBPα through the Akt signaling pathway
por: Jiang, Tiantuan, et al.
Publicado: (2019) -
Twist 1 regulates the expression of PPARγ during hormone-induced 3T3-L1 preadipocyte differentiation: a possible role in obesity and associated diseases
por: Ma, Wanshan, et al.
Publicado: (2014) -
PPAR γ/Nnat/NF-κB Axis Involved in Promoting Effects of Adiponectin on Preadipocyte Differentiation
por: Yang, Wenkai, et al.
Publicado: (2019)